Blockchain Registration Transaction Record

Lantern Pharma Launches Global AI Hub in India to Industrialize Drug Discovery

Lantern Pharma establishes an AI Center of Excellence in Bengaluru to scale its RADR® platform for faster, AI-driven oncology drug discovery and development.

This development matters because it represents a tangible acceleration in the application of artificial intelligence to one of humanity's most critical challenges: developing new medicines. Traditional drug discovery is notoriously slow, expensive, and prone to failure. By industrializing its AI platform in a major global tech hub, Lantern Pharma is scaling a methodology that could drastically reduce the time and cost to identify and optimize new cancer therapies. For patients, especially those with cancers defined by specific genomic markers, this approach promises more targeted, effective treatments developed through smarter, data-driven clinical trials. For the biotech and pharmaceutical industries, it showcases a viable model for leveraging AI at scale, potentially setting a new standard for R&D efficiency. The move also highlights the globalization of biotech innovation, tapping into India's deep pool of technical talent to solve complex biological problems, which could influence where future life sciences research and development clusters emerge.